Humana Inc

Chart & Performance

D1W1MN

P/E

12.39

P/S

0.29

EPS

20.67

Div Yield, %

1.40%

Shrs. gr., 5y

-2.10%

Rev. gr., 5y

13.33%

Revenues

106.37b

+14.54%

Net income

2.49b

-11.30%

CFO

3.98b

-13.21%

Dividend

Dec 31, 20240.885 USD/sh

Earnings

Jan 23, 2025

Profile

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

URL

https://www.humana.com/

IPO date

May 18, 1971

Employees

67,100

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	106,374,000 14.54%	92,870,000 11.81%	83,064,000 7.66%
Cost of revenue	13,188,000	12,671,000	10,121,000
Unusual Expense (Income)
NOPBT	93,186,000	80,199,000	72,943,000
NOPBT Margin	87.60%	86.36%	87.82%
Operating Taxes	836,000	762,000	485,000
Tax Rate	0.90%	0.95%	0.66%
NOPAT	92,350,000	79,437,000	72,458,000
Net income	2,489,000 -11.30%	2,806,000 -4.33%	2,933,000 -12.89%
Dividends	(431,000)	(392,000)	(354,000)
Dividend yield	0.76%	0.60%	0.59%
Proceeds from repurchase of equity	(1,573,000)	(2,096,000)	5,784,000
BB yield	2.76%	3.22%	-9.64%
Debt
Debt current	1,443,000	2,263,000	2,138,000
Long-term debt	10,657,000	9,490,000	11,087,000
Deferred revenue		286,000	254,000
Other long-term liabilities	1,662,000	(1,164,000)	(1,530,000)
Net debt	(10,342,000)	20,197,000	22,435,000
Cash flow
Cash from operating activities	3,981,000	4,587,000	2,262,000
CAPEX	(1,004,000)	(1,120,000)	(1,316,000)
Cash from investing activities	(3,492,000)	(1,006,000)	(6,556,000)
Cash from financing activities	(856,000)	(1,914,000)	3,015,000
FCF	82,692,000	79,507,000	73,322,000
Balance
Cash	21,320,000	5,061,000	3,394,000
Long term investments	1,122,000	(13,505,000)	(12,604,000)
Excess cash	17,123,300
Stockholders' equity	26,630,000	24,280,000	23,184,000
Invested Capital	12,512,700	27,262,000	29,874,000
ROIC	464.37%	278.06%	282.95%
ROCE	314.44%	285.00%	234.05%
EV
Common stock shares outstanding	124,441	127,094	129,396
Price	457.81 -10.62%	512.19 10.42%	463.86 13.06%
Market cap	56,970,334 -12.48%	65,096,276 8.45%	60,021,629 9.99%
EV	46,684,334	85,352,276	82,479,629
EBITDA	94,103,000	81,044,000	73,656,000
EV/EBITDA	0.50	1.05	1.12
Interest	493,000	401,000	326,000
Interest/NOPBT	0.53%	0.50%	0.45%